» Articles » PMID: 31926267

The Role of Macrophages in Osteoarthritis and Cartilage Repair

Overview
Date 2020 Jan 12
PMID 31926267
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is a family of degenerative diseases affecting multiple joint tissues. Despite the diverse etiology and pathogenesis of OA, increasing evidence suggests that macrophages can play a significant role in modulating joint inflammation, and thus OA severity, via various secreted mediators. Recent advances in next-generation sequencing technologies coupled with proteomic and epigenetic tools have greatly facilitated research to elucidate the embryonic origin of macrophages in various tissues including joint synovium. Furthermore, scientists have now begun to appreciate that macrophage polarization can span beyond the conventionally recognized binary states (i.e., pro-inflammatory M1-like vs anti-inflammatory M2-like) and may encompass a broad spectrum of phenotypes. Although the presence of these cells has been shown in multiple joint tissues, additional mechanistic studies are required to provide a comprehensive understanding of the precise role of these diverse macrophage populations in OA onset and progression. New approaches that can modulate macrophages into desired functional phenotypes may provide novel therapeutic strategies for preventing OA or enhancing cartilage repair and regeneration.

Citing Articles

Identification of Energy Metabolism-Related Subtypes and Diagnostic Biomarkers for Osteoarthritis by Integrating Bioinformatics and Machine Learning.

Xu S, Ye J, Cai X J Multidiscip Healthc. 2025; 18:1353-1369.

PMID: 40060994 PMC: 11890432. DOI: 10.2147/JMDH.S510308.


Akt2 inhibition alleviates temporomandibular joint osteoarthritis by preventing subchondral bone loss.

Feng S, Cao M, Gao C, Li Y, Lei J, Fu K Arthritis Res Ther. 2025; 27(1):43.

PMID: 40016746 PMC: 11866854. DOI: 10.1186/s13075-025-03506-x.


MSCs-EVs harboring OA immune memory reprogram macrophage phenotype via modulation of the mt-ND3/NADH-CoQ axis for OA treatment.

Zhan J, Zou J, Pang Q, Chen Z, Liu J, Liu S J Nanobiotechnology. 2025; 23(1):140.

PMID: 40001168 PMC: 11863759. DOI: 10.1186/s12951-025-03216-1.


Small extracellular vesicles derived from auricular chondrocytes promote secretion of interleukin 10 in bone marrow M1-like macrophages.

Kobatake T, Miyamoto Y, Fujihara Y, Saijo H, Hoshi K, Hikita A Regen Ther. 2025; 28:421-430.

PMID: 39925964 PMC: 11804269. DOI: 10.1016/j.reth.2025.01.009.


Ferroptosis and its role in osteoarthritis: mechanisms, biomarkers, and therapeutic perspectives.

Lu S, Liu Z, Qi M, Wang Y, Chang L, Bai X Front Cell Dev Biol. 2025; 12:1510390.

PMID: 39744014 PMC: 11688369. DOI: 10.3389/fcell.2024.1510390.


References
1.
Batoon L, Millard S, Wullschleger M, Preda C, Wu A, Kaur S . CD169 macrophages are critical for osteoblast maintenance and promote intramembranous and endochondral ossification during bone repair. Biomaterials. 2017; 196:51-66. DOI: 10.1016/j.biomaterials.2017.10.033. View

2.
Chuckpaiwong B, Charles H, Kraus V, Guilak F, Nunley J . Age-associated increases in the size of the infrapatellar fat pad in knee osteoarthritis as measured by 3T MRI. J Orthop Res. 2010; 28(9):1149-54. PMC: 3625521. DOI: 10.1002/jor.21125. View

3.
Blom A, van Lent P, Libregts S, Holthuysen A, van der Kraan P, van Rooijen N . Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum. 2006; 56(1):147-57. DOI: 10.1002/art.22337. View

4.
Udalova I, Mantovani A, Feldmann M . Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016; 12(8):472-85. DOI: 10.1038/nrrheum.2016.91. View

5.
Sakurai Y, Fujita M, Kawasaki S, Sanaki T, Yoshioka T, Higashino K . Contribution of synovial macrophages to rat advanced osteoarthritis pain resistant to cyclooxygenase inhibitors. Pain. 2018; 160(4):895-907. DOI: 10.1097/j.pain.0000000000001466. View